Brain Diseases

Global Experts Meeting on Frontiers in Alzheimer’s Disease & Dementia

Rome, Italy during Oct-14-16, 2019.

Session: Brain Diseases

Brain diseases occur in various forms of infection, trauma, stroke, convulsions, and tumors are some of the main categories of brain diseases. Here's an overview of various brain diseases.

• Migraine
• Attention deficit hyperactivity disorder
• Motor neuron disease
• Bipolar disorder
• Arteriovenous malformation.
• Encephalitis
• Seizures
• Stroke
• Psychological trauma
• Brain abscess

Submit your abstract on your interested session.

Register now on an appropriate package of your interest.

Dementia Care and Consulting

Global Experts Meeting on Frontiers in Alzheimer’s Disease & Dementia

Rome, Italy during Oct-14-16, 2019.

Session: Dementia Care and Consulting

The care of a dementia person influences different people in different ways. At all events, care can also be physically and rationally weakening. It influences all aspects of your life and can make you feel separated, pushed and even discouraged at times. You may also have your own physical and psychological well - being needs, which you and others may neglect when you look after someone else. There are many positive things to look after. These incorporate the adaptation of new skills, the expansion of existing skills, the strengthening of connections, a sense of pride in what you are doing and the support of someone who is imperative to you. In addition, because a man has dementia, it does not mean that there are no great circumstances to share with you.

• Dealing with Dementia Behaviour
• Dementia Risk and Preventions
• Dementia Awareness

Submit your abstract on your interested session.

Register now on an appropriate package of your interest.

Alzheimer’s Clinical Trials and Studies

Global Experts Meeting on Frontiers in Alzheimer’s Disease & Dementia

Rome, Italy during Oct-14-16, 2019.

Session: Alzheimer’s Clinical Trials and Studies

Clinical studies are asked about examinations in which people decide whether medicines are protected and feasible. There can be no better medicines, no counteractive action and no cure for Alzheimer's disease without clinical research and the assistance of human volunteers.

Clinical studies are sometimes referred to as clinical examinations; the terms are often used in reciprocal terms, but there are unobtrusive contrasts. Clinical studies test new intercessions or drugs to prevent, detect or treat infections. A clinical report is any kind of clinical research, including individuals, which pays little attention to whether or not they try to intercede. Clinical examinations can likewise take a gander at different parts of care, for example, enhancing personal satisfaction.

Submit your abstract on your interested session.

Register now on an appropriate package of your interest.

Vascular Dementia

Global Experts Meeting on Frontiers in Alzheimer’s Disease & Dementia

Rome, Italy during Oct-14-16, 2019.

Session: Vascular Dementia

Vascular dementia otherwise referred to as multi-infarct dementia, is the second most fundamental cause of dementia in more experienced persons. Since it has a lower profile than Alzheimer's, many people do not speculate that vascular dementia is noticeably dangerous when neglect occurs. It is also difficult to analyze, so it is difficult to know exactly how many people experience the ill effects of vascular dementia. Current assessments account for 15% to 20% of cases of dementia in more established adults with vascular dementia. Vascular dementia occurs when blood supplying vessels to the brain are significantly blocked or limited. Strokes occur when the blood supply that transmits oxygen to the mind is suddenly cut. However, not all people with a stroke develop vascular dementia. Vascular dementia may occur as " noiseless " strokes heap up after some time. Vascular dementia often attracts attention just when the effect of so many strokes means a notable handicap. Staying away from and controlling hazardous factors such as diabetes, hypertension, smoking and high cholesterol can help to control the risk of vascular dementia.

Submit your abstract on your interested session.

Register now on an appropriate package of your interest.

Neurodegenerative Diseases

Neurodegenerative diseases consist of a wide range of disorders characterized by nerve cell progressive degeneration or death. It affects the nervous tissue and also causes various neuropsychological effects. This is a term for a variety of conditions that affect neurons in the human brain in particular.

The development of neurodegenerative diseases has demonstrated that genetic and environmental factors play an important role. Age is one of the main risk factors common to all types of neurodegenerative disease as it commonly progresses in older age.

• Cognition
• Multiple Sclerosis
• Parkinson's disease
• Huntington's disease
• Neurovascular Dysfunction and Neurodegeneration

For abstract submission under the session PS:

 https://frontiersmeetings.com/conferences/dementia/Neurodegenerative-Diseases

Alzheimer’s Disease Pathophysiology and Disease Mechanisms

Alzheimer's disease is progressive dementia with neuron loss and two major neuropathological microscopic characteristics: extracellular amyloid plaques and intracellular neurofibrillary tangles. Early-onset of AD, a rare family form, is caused by one of three genes mutating: (amyloid precursor protein), (presenilin 2) or (presenilin 1). The sporadic form usually occurs after 65 years of age and is accountable in most cases; it most likely results from a combination of genetic and influence of environment. The age and presence of the E4 allele (Apolipoprotein E) are confirmed risk factors for sporadic AD. Amyloid plaques consist mainly of neurotoxic peptide amyloid (A?, Abeta), sequentially cleaved by two enzymes from a larger precursor protein (APP): ?-secretase (also referred to as BACE1) and ?-secretase (composed of four proteins, one of which is preseniline). If APP is cleaved by the ?-secretase enzyme instead of ?-secretase, A? is not formed.  Neurofibrillary tangles mainly consist of the protein tau that binds to microtubules and facilitates the neuronal transport system. Tau disassembly from microtubules and aggregation into tangles prevents transport and leads to microtubule disassembly. Tau phosphorylation could play an important role in this. The current rational pharmacological treatment is based on the selective vulnerability of neuronal systems, such as cholinergic, serotonergic and noradrenergic and glutamatergic systems.

This session includes Aging, Prions and Alzheimer’s disease, Cellular signaling and cell to cell transmission, Oxidative damage and mitochondrial dysfunction, Autoimmunity in Alzheimer’s, Blood-brain barrier, transport, Neurogenesis, stem cells, and Cell death.

For abstract submission under the session, please visit: 

https://frontiersmeetings.com/conferences/dementia/Alzheimers-Disease-Pathophysiology-and-Disease-Mechanisms

Alzheimer’s Disease Diagnosis and Symptoms

Alzheimer's is caused by the death of brain cells. It is a neurological disorder in which brain cell death leads to a loss of memory and a cognitive decline. The total brain shrinks in Alzheimer's, nerve cells and tissue connections that cannot be seen or tested in the living brain affected by Alzheimer's disease, post - mortem / autopsy always shows small inclusions in nerve tissues called plaques and tangles. Plaques are found between dying cells in the brain from the development of the beta-amyloid (amyloid plaques) protein.

Diagnosis: AD is typically diagnosed after healthcare providers perform tests and look at health history to help determine whether a person's memory problems or other mental skills are declining over time. Your doctor may:

• Ask about your medical history, your ability to carry out routine tasks, and changes in your behavior or personality.
• Perform tests to assess your memory, problem-solving, attention, counting, and language skills.
• Order medical tests to check your urine, blood, and spinal fluid.
• Conduct brain scans, such as computed tomography (CT) scan or magnetic resonance imaging (MRI) test.

Symptoms:

• Inability to communicate
• Inability to recognize oneself or family
• Weight loss
• Difficulty swallowing
• Groaning or grunting
• Increased sleeping
• Lack of bowel and bladder control

For more details about the session PS: https://frontiersmeetings.com/conferences/dementia/Alzheimers-Disease-Diagnosis-and-Symptoms